Oklahoma City is in the middle of an ever-changing world as a city on the brink of change itself. In today’s global economy, the city would often be viewed as a pitstop on the way to a “bigger and better” destination. But to anyone who has driven I-35 through the nation’s heartland and turned that pitstop into a lengthy, Oklahoma “stay awhile,” they would have noticed something worth staying for and investing in. 

In the rearview are days when Oklahoma City’s key sectors – academia, aerospace, bioscience, energy, healthcare, manufacturing and research – worked solely in silos, and on the road ahead lie opportunities for those industries to cross, merge and collaborate, giving the city a future at becoming a stable, international competitor in the ever-changing global economy. 

A group who has seen the road ahead is General Genomics, a company whose story is built on cross-industry collaboration leading to innovation – the very thing the Oklahoma City Innovation District’s mission stands on. 

General Genomics is a bioinformatics artificial intelligence platform, a company that fuses biology and information to interpret and understand data from living organisms. The company was founded by A.J. Rosenthal, Warren Gieck and Caleb Stuart, and behind their three backgrounds lies seven industries: energy, engineering, entrepreneurship, investment, legal, military and science, all of which come together to make General Genomics what it is – a trendsetter in the biotech industry, an industry that happens to be unfamiliar to each of them until now and now the eighth industry added to their collective resume. 

Oklahoma City’s regional biotech scene has been being built for decades, and that strategic focus has launched the region into one of the fastest growing biotech hubs in the U.S. Since the establishment of the Oklahoma Medical Research Foundation (OMRF) in 1946, the region has witnessed unprecedented growth and reinvestment in biotech capabilities, expertise and resources. The addition of General Genomics capabilities only adds to that as they join the ranks of some of the nation’s biotech leaders in Oklahoma City, one of several reasons why the company chose OKC as a headquarters to launch its bio/tech venture.

Read the full story on VeloCityOKC.com.